Edwards Lifesciences Corp. (NYSE: EW) reported Q1 EPS of $0.76, $0.07 better than the analyst estimate of $0.69. Revenue for the quarter came in at $522.4 million versus the consensus estimate of $523.1 million.

Edwards Lifesciences Corp. sees FY2014 EPS of $3.10, versus the consensus of $3.06. Edwards Lifesciences Corp. sees FY2014 revenue of $2.05-2.25 million, versus the consensus of $2.16 million.

Edwards Lifesciences Corp. sees Q2 2014 EPS of $0.71-$0.81, versus the consensus of $0.76. Edwards Lifesciences Corp. sees Q2 2014 revenue of $525-565 million, versus the consensus of $543.16 million.

For earnings history and earnings-related data on Edwards Lifesciences Corp. (EW) click here.